December 2020 - Partnership between Ozyme and Codex DNA
Codex DNA's mission is to equip scientific researchers with the necessary methodologies to quickly and accurately produce large quantities of synthetic genes. Ozyme completes its offering on cloning solutions by integrating products from Codex DNA, a company co-founded by Dan Gibson, the inventor of Gibson cloning technology recognized as the gold standard, into its catalog.
Gibson Assembly® kits are the most recent versions generating the best cloning efficiency.
The product portfolio also includes Vmax ™ competent cells for the production of proteins in bacteria. This system makes it possible to generate significantly larger quantities of biomass than traditional systems for the expression of bacterial proteins.
Ozyme completes its antibody offering by including Jackson Immuno Research (JIR), a recognized specialist in secondary antibodies, in its catalog.
Jackson Immuno Research is an American company of more than 35 years specialized in the production and the purification of secondary antibodies conjugated to a large choice of fluorophores, enzymes (HRP, PA) or gold beads validated for a large number of applications (IF, FC, IHC, ELISA, WB, electron microscopy…).
Corning is a company developing new tools and technologies for researchers in the life sciences. Their R&D experts meet the growing need for reliable reagents for cell culture. It is this expertise, added to 160 years of innovation and excellence, that positions Corning to offer a complete portfolio of high-quality media and consumables in cell culture.
Ozyme signs an agreement with the company Integrated DNA Technologies for the marketing of high quality reagents in genomics, and in particular:
Integrated DNA Technologies is the world leader in the manufacturing of custom oligonucleotides for academic laboratories, medical diagnostics, biotechnology companies, agriculture and pharmaceutical development.
Partnership between Ozyme and Azure Biosystems for the range of imagers (gels and Western blot) and scanners
Ozyme expands its offer for Western Blot and IP by marketing the antibodies of Bethyl Laboratories, Inc. This range represents more than 19,000 references of antibodies for WB, IP and also ELISA and IHC in cancer, cardiovascular system, cell biology, immunology, neurobiology and signal transduction.